CORONA, Calif., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Acology’s latest quarterly report has been released. Here are some of the
highlights:
- Business is up 33% over same period last year and trending higher
- Sales exceeded $1.1 M, which reflected a nearly 10% increase over the past year
- Acology’s portfolio increased by an instant $2.5M with the purchase of the MedTainer™ intellectual property
- Inventory control is well in hand despite the surge in product orders
- Acology remains one of the few fully-reported and audited stock companies in this sector
The cannabis industry has begun to take increased notice of Acology and the MedTainer as an essential pre-packaged retail
partner, especially in the Canadian sector, where Acology products are perfectly positioned to fulfill the compliance rules that
the Canadian Government has posted. In approximately 8 weeks, as licensed Canadian retailers open their stores and customers are
finally able to begin purchasing legal cannabis experts predict that it will see sharp increases in the entire sector, including
Acology. This was the main reason that Acology purchased and re-registered, at considerable expense, the intellectual property
mentioned above. More Licensed Producers in Canada have ordered customized MedTainers. The company’s decision to invest
considerable resources in April have been justified and the focus now is on increasing sales to all Acology distributors and
landing Purchase Orders from the LPs. Acology’s LP orders have increased month-over-month. The company is also continuing to
diversify its product line and sales of the MedX 2-Way Humidity Packs are rising steadily. The market notes that this to the fact
that the system is far superior to any other product on the market. This assertion is based on both the science and the performance
of the product. Each MedTainer is now pre-packaged with a 4gr pack. Retailers and customers have been extremely enthusiastic with
this extra-added bonus. Acology’s management believes that its position has never been better and the company’s financials bear
this out.
For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located
in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.
Acology trades on the OTC under the call letters ACOL. The company’s websites are www.Acologyinc.com for the hospice and
palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products
can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to info@acologyinc.com or
call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services Director. Acology can also be accessed through
Twitter and Instagram at @Acologyinc
This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such
statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond
could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as
“anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that
indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in
the loss of some or all of his or her investment.
